OBJECTIVES: The goal of this study was to determine the ability of a single, resting high-sensitivity troponin T (hsTnT) measurement to predict abnormal myocardial perfusion imaging (MPI) in patients presenting with acute chest pain to the emergency department (ED). BACKGROUND: HsTnT assays precisely detect very low levels of troponin T, which may be a surrogate for the presence and extent of myocardial ischemia. METHODS: We included all patients from the ROMICAT I (Rule Out Myocardial Infarction Using Computer Assisted Tomography) trial, an observational cohort study, who underwent both single-photon emission computed tomography (SPECT)-MPI stress testing and 64-slice computed tomography angiography (CTA) and in whom hsTnT measurements were available. We assessed the discriminatory value of hsTnT for abnormal SPECT-MPI and the association of reversible myocardial ischemia by SPECT-MPI and the extent of coronary atherosclerosis by CTA to hsTnT levels. RESULTS: Of the 138 patients (mean age 54 ± 11 years, 46% male), 19 (13.7%) had abnormal SPECT-MPI. Median hsTnT levels were significantly different between patients with normal and abnormal SPECT-MPI (9.41 pg/ml [interquartile range (IQR): 5.73 to 19.20 pg/ml] vs. 4.89 pg/ml [IQR: 2.34 to 7.68 pg/ml], p = 0.001). Sensitivity of 80% and 90% to detect abnormal SPECT-MPI was reached at hsTnT levels as low as 5.73 and 4.26 pg/ml, respectively. Corresponding specificity was 62% and 46%, and negative predictive value was 96% and 96%, respectively. HsTnT levels had good discriminatory ability for prediction of abnormal SPECT-MPI (area under the curve: 0.739, 95% confidence interval: 0.609 to 0.868). Both reversible myocardial ischemia and the extent of coronary atherosclerosis (combined model r(2) = 0.19 with partial of r(2) = 0.12 and r(2) = 0.05, respectively) independently and incrementally predicted the measured hsTnT levels. CONCLUSIONS: In patients with acute chest pain, myocardial perfusion abnormalities and coronary artery disease are predicted by resting hsTnT levels. Prospective evaluations are warranted to confirm whether resting hsTnT could serve as a powerful triage tool in chest pain patients in the ED before diagnostic testing and improve the effectiveness of patient management.
OBJECTIVES: The goal of this study was to determine the ability of a single, resting high-sensitivity troponin T (hsTnT) measurement to predict abnormal myocardial perfusion imaging (MPI) in patients presenting with acute chest pain to the emergency department (ED). BACKGROUND: HsTnT assays precisely detect very low levels of troponin T, which may be a surrogate for the presence and extent of myocardial ischemia. METHODS: We included all patients from the ROMICAT I (Rule Out Myocardial Infarction Using Computer Assisted Tomography) trial, an observational cohort study, who underwent both single-photon emission computed tomography (SPECT)-MPI stress testing and 64-slice computed tomography angiography (CTA) and in whom hsTnT measurements were available. We assessed the discriminatory value of hsTnT for abnormal SPECT-MPI and the association of reversible myocardial ischemia by SPECT-MPI and the extent of coronary atherosclerosis by CTA to hsTnT levels. RESULTS: Of the 138 patients (mean age 54 ± 11 years, 46% male), 19 (13.7%) had abnormal SPECT-MPI. Median hsTnT levels were significantly different between patients with normal and abnormal SPECT-MPI (9.41 pg/ml [interquartile range (IQR): 5.73 to 19.20 pg/ml] vs. 4.89 pg/ml [IQR: 2.34 to 7.68 pg/ml], p = 0.001). Sensitivity of 80% and 90% to detect abnormal SPECT-MPI was reached at hsTnT levels as low as 5.73 and 4.26 pg/ml, respectively. Corresponding specificity was 62% and 46%, and negative predictive value was 96% and 96%, respectively. HsTnT levels had good discriminatory ability for prediction of abnormal SPECT-MPI (area under the curve: 0.739, 95% confidence interval: 0.609 to 0.868). Both reversible myocardial ischemia and the extent of coronary atherosclerosis (combined model r(2) = 0.19 with partial of r(2) = 0.12 and r(2) = 0.05, respectively) independently and incrementally predicted the measured hsTnT levels. CONCLUSIONS: In patients with acute chest pain, myocardial perfusion abnormalities and coronary artery disease are predicted by resting hsTnT levels. Prospective evaluations are warranted to confirm whether resting hsTnT could serve as a powerful triage tool in chest painpatients in the ED before diagnostic testing and improve the effectiveness of patient management.
Authors: Lori B Daniels; Gail A Laughlin; Paul Clopton; Alan S Maisel; Elizabeth Barrett-Connor Journal: J Am Coll Cardiol Date: 2008-08-05 Impact factor: 24.094
Authors: Udo Hoffmann; Fabian Bamberg; Claudia U Chae; John H Nichols; Ian S Rogers; Sujith K Seneviratne; Quynh A Truong; Ricardo C Cury; Suhny Abbara; Michael D Shapiro; Jamaluddin Moloo; Javed Butler; Maros Ferencik; Hang Lee; Ik-Kyung Jang; Blair A Parry; David F Brown; James E Udelson; Stephan Achenbach; Thomas J Brady; John T Nagurney Journal: J Am Coll Cardiol Date: 2009-05-05 Impact factor: 24.094
Authors: Gabija Pundziute; Joanne D Schuijf; J Wouter Jukema; Isabel Decramer; Giovanna Sarno; Piet K Vanhoenacker; Eric Boersma; Johan H C Reiber; Martin J Schalij; William Wijns; Jeroen J Bax Journal: Eur Heart J Date: 2008-08-05 Impact factor: 29.983
Authors: Fabian Bamberg; Nina Dannemann; Michael D Shapiro; Sujith K Seneviratne; Maros Ferencik; Javed Butler; Wolfgang Koenig; Khurram Nasir; Ricardo C Cury; Ahmed Tawakol; Stephan Achenbach; Thomas J Brady; Udo Hoffmann Journal: Arterioscler Thromb Vasc Biol Date: 2008-01-03 Impact factor: 8.311
Authors: Amit Pursnani; Ashley M Lee; Thomas Mayrhofer; Waleed Ahmed; Shanmugam Uthamalingam; Maros Ferencik; Stefan B Puchner; Fabian Bamberg; Christopher L Schlett; James Udelson; Udo Hoffmann; Brian B Ghoshhajra Journal: Circ Cardiovasc Imaging Date: 2015-03 Impact factor: 7.792
Authors: Stefan B Puchner; Ting Liu; Thomas Mayrhofer; Quynh A Truong; Hang Lee; Jerome L Fleg; John T Nagurney; James E Udelson; Udo Hoffmann; Maros Ferencik Journal: J Am Coll Cardiol Date: 2014-08-19 Impact factor: 24.094
Authors: Maros Ferencik; Thomas Mayrhofer; Michael T Lu; Pamela K Woodard; Quynh A Truong; W Frank Peacock; Fabian Bamberg; Benjamin C Sun; Jerome L Fleg; John T Nagurney; James E Udelson; Wolfgang Koenig; James L Januzzi; Udo Hoffmann Journal: Clin Chem Date: 2017-09-18 Impact factor: 8.327
Authors: Muhammad Hammadah; Jeong Hwan Kim; Ayman Samman Tahhan; Bryan Kindya; Chang Liu; Yi-An Ko; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Ayman Alkhoder; Fahad Choudhary; Mohamad Mazen Gafeer; Naser Abdelhadi; Pratik Pimple; Pratik Sandesara; Bruno B Lima; Amit J Shah; Laura Ward; Michael Kutner; J Douglas Bremner; David S Sheps; Paolo Raggi; Laurence S Sperling; Viola Vaccarino; Arshed A Quyyumi Journal: Ann Intern Med Date: 2018-11-06 Impact factor: 25.391
Authors: Muhammad Hammadah; Ayman Samman Tahhan; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Bryan R Kindya; Heval M Kelli; Wesley T O'Neal; Pratik Sandesara; Samaah Sullivan; Zakaria Almuwaqqat; Malik Obideen; Naser Abdelhadi; Ayman Alkhoder; Pratik M Pimple; Oleksiy Levantsevych; Kareem H Mohammed; Lei Weng; Laurence S Sperling; Amit J Shah; Yan V Sun; Brad D Pearce; Michael Kutner; Laura Ward; J Douglas Bremner; Jinhee Kim; Edmund K Waller; Paolo Raggi; David Sheps; Viola Vaccarino; Arshed A Quyyumi Journal: J Am Heart Assoc Date: 2018-02-10 Impact factor: 5.501